{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:13:46Z","timestamp":1783012426132,"version":"3.54.6"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209083","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T12:41:29Z","timestamp":1685104889000},"page":"209083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use"],"prefix":"10.1016","volume":"155","author":[{"given":"Carla L.","family":"DeSisto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akadia","family":"Kacha-Ochana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanna","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209083_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1016\/j.josat.2023.209083_bb0010","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","article-title":"Addressing racial and ethnic disparities in the use of medications for opioid use disorder","volume":"40","author":"Andraka-Christou","year":"2021","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2023.209083_bb0015","article-title":"Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder","author":"Andrilla","year":"2021","journal-title":"Journal of Rural Health."},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0020","article-title":"Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19","volume":"27","author":"Bachireddy","year":"2021","journal-title":"American Journal of Managed Care"},{"issue":"11","key":"10.1016\/j.josat.2023.209083_bb0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.addbeh.2010.06.018","article-title":"Gender and prescription opioids: Findings from the National Survey on Drug Use and Health","volume":"35","author":"Back","year":"2010","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209083_bb0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsat.2016.12.012","article-title":"The Juvenile Justice Behavioral Health Services Cascade: A new framework for measuring unmet substance use treatment services needs among adolescent offenders","volume":"74","author":"Belenko","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209083_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugalcdep.2007.04.005","article-title":"Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002","volume":"90","author":"Blanco","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0040","article-title":"Treatment of opioid use disorder in primary care","volume":"373","author":"Buresh","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.josat.2023.209083_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1037\/0893-164X.15.1.4","article-title":"Initial validation of a computer-administered Addiction Severity Index: The ASI-MV","volume":"15","author":"Butler","year":"2001","journal-title":"Psychology of Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.josat.2023.209083_bb0050","doi-asserted-by":"crossref","DOI":"10.2196\/16038","article-title":"How motivations for using buprenorphine products differ from using opioid analgesics: Evidence from an observational study of internet discussions among recreational users","volume":"6","author":"Butler","year":"2020","journal-title":"JMIR Public Health and Surveillance"},{"issue":"12","key":"10.1016\/j.josat.2023.209083_bb0055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/pds.1659","article-title":"National Addictions Vigilance Intervention and Prevention Program (NAVIPPROTM): A real-time, product-specific, public health surveillance system for monitoring prescription drug abuse","volume":"17","author":"Butler","year":"2008","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102722","article-title":"Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?","volume":"79","author":"Carlson","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"6","key":"10.1016\/j.josat.2023.209083_bb0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ADM.0000000000000436","article-title":"The more things change: Buprenorphine\/naloxone diversion continues while treatment remains inaccessible","volume":"12","author":"Carroll","year":"2018","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209083_bb0075","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2023.209083_bb0080","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.josat.2023.209083_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: Motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209083_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0095","author":"Drug Enforcement Administration"},{"issue":"1","key":"10.1016\/j.josat.2023.209083_bb0100","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"Ecker","year":"2019","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.josat.2023.209083_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsat.2018.07.011","article-title":"U.S. adults with opioid use disorder living with children: Treatment use and barriers to care","volume":"93","author":"Feder","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2023.209083_bb0110","doi-asserted-by":"crossref","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209083_bb0115","series-title":"Drug and alcohol dependence (Vol. 86, Issue 1, pp. 1\u201321). Drug alcohol depend","article-title":"Substance abuse treatment entry, retention, and outcome in women: A review of the literature","author":"Greenfield","year":"2007"},{"issue":"1","key":"10.1016\/j.josat.2023.209083_bb0120","first-page":"1","article-title":"Gender disparities in opioid treatment progress in methadone versus counseling","volume":"16","author":"Guerrero","year":"2021","journal-title":"Substance Abuse Treatment, Prevention, and Policy 2021 16:1"},{"key":"10.1016\/j.josat.2023.209083_bb0125","author":"Guttmacher Institute"},{"issue":"26","key":"10.1016\/j.josat.2023.209083_bb0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: Changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.josat.2023.209083_bb0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29409","article-title":"Trends in and characteristics of buprenorphine misuse among adults in the US","volume":"4","author":"Han","year":"2021","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"Journal of Behavioral Health Services and Research"},{"issue":"5","key":"10.1016\/j.josat.2023.209083_bb0145","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1360-0443.2011.03740.x","article-title":"A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries","volume":"107","author":"Humeniuk","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2023.209083_bb0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073110518782949","article-title":"The opioid crisis in black communities","volume":"46","author":"James","year":"2018","journal-title":"Journal of Law, Medicine and Ethics"},{"issue":"23","key":"10.1016\/j.josat.2023.209083_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15585\/mmwr.mm7123a1","article-title":"Characteristics of adults aged \u226518 years evaluated for substance use and treatment planning - United States, 2019","volume":"71","author":"Kacha-Ochana","year":"2022","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"5","key":"10.1016\/j.josat.2023.209083_bb0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41372-019-0535-2","article-title":"Obstetrician\u2013gynecologists\u2019 practice patterns related to opioid use during pregnancy and postpartum\u2014United States, 2017","volume":"40","author":"Ko","year":"2019","journal-title":"Journal of Perinatology"},{"key":"10.1016\/j.josat.2023.209083_bb0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.drugalcdep.2017.06.009","article-title":"Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample","volume":"178","author":"Krawczyk","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108512","article-title":"Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample","volume":"220","author":"Krawczyk","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209083_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/ADM.0000000000000820","article-title":"Utilization of medications for opioid use disorder across US states: Relationship to treatment availability and overdose mortality","volume":"16","author":"Krawczyk","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209083_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209083_bb0190","series-title":"JAMA Psychiatry (Vol. 76, Issue 9, pp. 979\u2013981)","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","author":"Lagisetty","year":"2019"},{"issue":"6","key":"10.1016\/j.josat.2023.209083_bb0195","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.josat.2023.209083_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108399","article-title":"Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities","volume":"127","author":"Marsh","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209083_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107679","article-title":"Unmet substance use disorder treatment need among reproductive age women","volume":"206","author":"Martin","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2023.209083_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2023.209083_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","article-title":"\u201cThey\u2019re making it so hard for people to get help:\u201d Motivations for non-prescribed buprenorphine use in a time of treatment expansion","volume":"71","author":"McLean","year":"2019","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2023.209083_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29043","article-title":"Prevalence and geographic distribution of obstetrician-gynecologists who treat Medicaid enrollees and are trained to prescribe buprenorphine","volume":"3","author":"Nguemeni Tiako","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209083_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","article-title":"Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey","volume":"98","author":"Novak","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0235","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pain.2008.01.027","article-title":"Prevalence and characteristics of opioid use in the US adult population","volume":"138","author":"Parsells Kelly","year":"2008","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.josat.2023.209083_bb0240","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"Journal of Perinatology"},{"issue":"8","key":"10.1016\/j.josat.2023.209083_bb0245","doi-asserted-by":"crossref","first-page":"2013456","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Network Open"},{"issue":"18","key":"10.1016\/j.josat.2023.209083_bb0250","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA - Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/j.josat.2023.209083_bb0255","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Network Open"},{"issue":"5152","key":"10.1016\/j.josat.2023.209083_bb0260","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2023.209083_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108710","article-title":"Growing racial\/ethnic disparities in buprenorphine distribution in the United States, 2007-2017","volume":"223","author":"Schuler","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","author":"Sharma","year":"2017","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.josat.2023.209083_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107958","article-title":"On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine","volume":"210","author":"Silverstein","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209083_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109924","article-title":"Increasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program","volume":"303","author":"Simpson","year":"2019","journal-title":"Forensic Science International"},{"key":"10.1016\/j.josat.2023.209083_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107837","article-title":"Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky","volume":"208","author":"Smith","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2023.209083_bb0290","article-title":"Drug overdose deaths involving fentanyl, 2011-2016","volume":"68","author":"Spencer","year":"2018","journal-title":"National Vital Statistics Reports"},{"key":"10.1016\/j.josat.2023.209083_bb0295","series-title":"A collaborative approach to the treatment of pregnant women with opioid use disorders","author":"Substance Abuse and Mental Health Services Administration","year":"2016"},{"key":"10.1016\/j.josat.2023.209083_bb0300","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.209083_bb0305","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.209083_bb0310","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.209083_bb0320","series-title":"Indian Health Service (IHS)","author":"U.S. Department of Health and Human Services","year":"2022"},{"key":"10.1016\/j.josat.2023.209083_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2021.02.026","article-title":"Association between buprenorphine for opioid use disorder and mortality risk","author":"Vakkalanka","year":"2021","journal-title":"American Journal of Preventive Medicine."},{"key":"10.1016\/j.josat.2023.209083_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.05.017","article-title":"Future directions for medication assisted treatment for opioid use disorder with American Indian\/Alaska Natives","volume":"86","author":"Venner","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.josat.2023.209083_bb0335","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209083_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108770","article-title":"Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder","volume":"139","author":"Williams","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.josat.2023.209083_bb0345","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/jwh.2018.7597","article-title":"Treatment of substance use disorders among women of reproductive age by depression and anxiety disorder status, 2008-2014","volume":"28","author":"Zhou","year":"2019","journal-title":"Journal of Women\u2019s Health"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:52:23Z","timestamp":1757433143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":68,"alternative-id":["S2949875923001340"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209083","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209083"}}